Mettler-Toledo International, Inc. (MTD) vs Natera, Inc. (NTRA)

Mettler-Toledo International, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $58.4B against $32.8B — 1.8× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Mettler-Toledo International, Inc. trades at 36.4×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs −7.11%) and the higher return on invested capital (35.4% vs −22.3%). Across the 20 metrics below, Mettler-Toledo International, Inc. leads on 13 and Natera, Inc. on 7.

Valuation

Metric MTD NTRA Diagnostics & Research median
P/E 36.42 n/m 35.56
P/S 7.90 20.75 4.37
P/B 2,545.64 30.83 3.06
Price to free cash flow 37.78 667.04 35.76
EV/EBITDA 26.59 n/m 24.35
EV/Sales 8.40 20.48 5.51
Earnings yield 2.75% (0.35%) (1.89%)
Free cash flow yield 2.65% 0.15% (0.15%)

Profitability

Metric MTD NTRA Diagnostics & Research median
Gross margin 60.26% 65.23% 50.89%
Operating margin 28.41% (10.70%) (8.57%)
Net margin 21.91% (7.11%) (6.37%)
Free cash flow margin 20.90% 3.11% 0.00%
Return on equity (736.36%) (12.54%) (2.92%)
Return on assets 25.61% (8.71%) (6.71%)
Return on invested capital 35.40% (22.34%) 0.00%

Growth

Metric MTD NTRA Diagnostics & Research median
Revenue growth (TTM) 6.91% 37.82% 7.69%
EPS growth (last fiscal year) 3.88% 0.65% 25.92%
Revenue growth, 5-year CAGR 5.47% 42.61% 7.40%
Net income growth, 5-year CAGR 7.60% 0.00% 0.00%

Health

Metric MTD NTRA Diagnostics & Research median
Debt to equity 164.70 0.04 0.11
Current ratio 1.12 3.00 2.02
Net debt to EBITDA 1.68 3.74 0.70

Dividend

Metric MTD NTRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MTD NTRA Diagnostics & Research median
Market cap 32.84b 58.35b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack